Cargando…

Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis

OBJECTIVE: Integration of risk stratification into fecal immunochemical test (FIT) might aid in the suboptimal detection of advanced neoplasms by FIT in colorectal cancer (CRC) screening. A comparative study was conducted to evaluate the participation and diagnostic yield of the parallel combination...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hongda, Wang, Le, Lu, Ming, Zhu, Chen, Zhu, Yunfeng, Ma, Weihua, Chen, Xinmin, Du, Lingbin, Chen, Wanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435825/ https://www.ncbi.nlm.nih.gov/pubmed/34584376 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.04.08

Ejemplares similares

One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China
por: Wang, Le, et al.
Publicado: (2022)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program
por: Law, Jade, et al.
Publicado: (2021)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms
por: Chiang, Tsung-Hsien, et al.
Publicado: (2015)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test
por: He, Xu-xia, et al.
Publicado: (2019)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
por: Xu, Hongli, et al.
Publicado: (2022)

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
por: van der Vlugt, Manon, et al.
Publicado: (2022)

Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening
por: Cai, Shan-Rong, et al.
Publicado: (2016)

Clinical Features of Fecal Immunochemical Test-Negative Colorectal Lesions based on Colorectal Cancer Screening among Asymptomatic Participants in Their 50s
por: Suto, Shinya, et al.
Publicado: (2022)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
por: Chiu, Han-Mo, et al.
Publicado: (2015)

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
por: Mikkelsen, Ellen M, et al.
Publicado: (2018)

Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
por: Ibáñez-Sanz, Gemma, et al.
Publicado: (2022)

Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial
por: Strömberg, U., et al.
Publicado: (2022)

Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening Program
por: Moosavi, Sarvenaz, et al.
Publicado: (2016)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
por: Malagón, Marta, et al.
Publicado: (2020)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021)

Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
por: Trivedi, Mehul, et al.
Publicado: (2022)

Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening
por: Burns, Shohei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u6mlqce2na20elhl4agf6vkkh3